Skip to main content
. 2017 Jul 3;4(1):e000196. doi: 10.1136/bmjresp-2017-000196

Table 1.

Characteristics of 79 consecutive patients with COPD and Spearman’s rank correlation coefficients between the total Kihon Checklist scores and those of clinical indices

Variable n Mean±SD Range Rs p Value
Age (years) 79 74.8±6.3 60–88 0.006 0.96
BMI (kg/m2) 79 22.4±3.1 13.6–30.7 0.097 0.39
Cumulative smoking pack-years 79 57.4±31.4 10–204 −0.12 0.30
VC (L) 79 3.14±0.73 1.76–5.61 −0.34* <0.01
VC (% pred) 79 96.5±17.5 59.1–138.5 −0.24* 0.04
FVC (L) 79 3.09±0.74 1.73–5.34 −0.34* <0.01
FVC (% pred) 79 97.8±18.6 53.5–138.0 −0.21 0.07
FEV1 (L) 79 1.72±0.56 0.49–3.08 −0.33* <0.01
FEV1 (% pred) 79 69.3±20.4 21.1–114.1 −0.15 0.19
FEV1/FVC (%) 79 55.4±11.0 21.9–61.0 −0.13 0.24
IC (L) 79 2.10±0.56 1.02–3.97 −0.17 0.13
IC/TLC (%) 79 37.9±11.0 10.9–83.8 −0.01 0.93
TLC (% pred) 79 107.3±27.6 48.5–238.6 −0.19 0.09
DLCO (mL/min/mmHg) 79 11.61±4.63 1.72–25.84 −0.29* 0.01
DLCO (% pred) 79 50.7±19.1 7.6–101.4 −0.24* 0.03
DLCO/VA (mL/min/mmHg/L) 79 2.59±0.93 0.23–4.29 −0.14 0.22
PaO2 (mmHg) 79 78.5±9.0 56.6–94.8 −0.16 0.15
CAT score 79 8.2±7.1 0–31 0.38* <0.01
SGRQ
  Symptom 79 37.5±19.1 2.7–90.3 0.26* 0.02
  Activity 79 31.6±26.8 0.0–93.3 0.63† <0.01
  Impacts 79 13.4±16.3 0.0–76.7 0.63† <0.01
  Total 79 22.8±18.0 1.9–83.7 0.65† <0.01
SF-36
  Physical functioning 73 41.1±15.0 −7.1–57.8 −0.60† <0.01
  Role physical 73 41.5±13.6 2.6–55.7 −0.33* <0.01
  Bodily pain 73 50.4±10.8 26.9–61.7 −0.49† <0.01
  General health 73 45.8±9.5 19.1–68.2 −0.64† <0.01
  Vitality 73 51.5±9.8 24.1–69.1 −0.59† <0.01
  Social functioning 73 49.1±10.7 18.4–57.0 −0.53† <0.01
  Role emotional 73 45.7±13.0 6.1–56.1 −0.31* <0.01
  Mental health 73 50.8±9.8 27.7–65.2 −0.51† <0.01
Hyland Scale score 79 66.6±16.9 20–100 −0.54† <0.01
BDI score 77 8.9±2.4 0–12 −0.46† <0.01
D-12 score 78 1.6±4.0 0–23 0.41† <0.01

Data are presented as mean±SD. A p value <0.05 was interpreted as statistically significant,

*Weak correlation coefficients (0.20–0.40).

†Moderate correlation coefficients (0.40–0.70).

% pred, percentage predicted; BDI, Baseline Dyspnea Index; BMI, body mass index; CAT, COPD Assessment Test; COPD, chronic obstructive pulmonary disease; D-12, Dyspnea-12.; DLCO, diffusing capacity of the lungs for carbon monoxide; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; IC, inspiratory capacity; PaO2, partial pressure of arterial oxygen; SF-36, Medical Outcomes Study 36-item short-form; SGRQ, St. George’s Respiratory Questionnaire; TLC, total lung capacity; VA, alveolar volume; VC, slow vital capacity.